- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 20, 2020
Translation in Brief
Vaxxas' temperature-stable, low-dose vaccine patch; plus Stanford screen for 3-D tumor targets, new invasion mechanism for SARS-CoV-2 and PharmaMar
BioCentury’s roundup of preclinical news
BioCentury | Sep 10, 2015
Distillery Therapeutics
Therapeutics: Basigin Ok blood group (BSG; EMMPRIN; CD147); P. falciparum reticulocyte-binding protein homolog 5 (PfRh5)
Items per page:
1 - 10 of 10